Cargando…
DFT investigation of atazanavir as potential inhibitor for 2019-nCoV coronavirus M protease
Atazanavir (ATZ) is an antiviral drug synthesized.ATZ is being investigated for potential application against the Coronavirus 2019-nCoV. To find candidate drugs for 2019-nCoV, we have carried out a computational study to screen for effective available drug ATZ which may work as an inhibitor for the...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568473/ https://www.ncbi.nlm.nih.gov/pubmed/33100379 http://dx.doi.org/10.1016/j.molstruc.2020.129461 |